Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewAmsterdam Pharma Co N.V (NAMS) Goodwill & Intangibles: 2022-2024

Historic Goodwill & Intangibles for NewAmsterdam Pharma Co N.V (NAMS) over the last 3 years, with Dec 2024 value amounting to $534,000.

  • NewAmsterdam Pharma Co N.V's Goodwill & Intangibles fell 25.97% to $439,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $439,000, marking a year-over-year decrease of 25.97%. This contributed to the annual value of $534,000 for FY2024, which is 214.12% up from last year.
  • Per NewAmsterdam Pharma Co N.V's latest filing, its Goodwill & Intangibles stood at $534,000 for FY2024, which was up 214.12% from $170,000 recorded in FY2023.
  • NewAmsterdam Pharma Co N.V's 5-year Goodwill & Intangibles high stood at $534,000 for FY2024, and its period low was $170,000 during FY2023.
  • Moreover, its 3-year median value for Goodwill & Intangibles was $208,000 (2022), whereas its average is $304,000.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first decreased by 18.27% in 2023, then surged by 214.12% in 2024.
  • Over the past 3 years, NewAmsterdam Pharma Co N.V's Goodwill & Intangibles (Yearly) stood at $208,000 in 2022, then dropped by 18.27% to $170,000 in 2023, then soared by 214.12% to $534,000 in 2024.